4
Changes in Ownership
ELITE PHARMACEUTICALS INC /NV/ Filed Acc 0001465825-12-000010
Director acquired 2,976,190 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
NARINE JEENARINE · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2011-07-06 | Conversion : show line 1 in the form | +2,976,190 | 3,384,139 | I |
Table II: Derivative
2 lines| Date | Transaction | Shares | Price | Value | Exercise | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|
| 2011-07-06 | Conversion : show line 2 in the form Series E Convertible Preferred Stock | −75 | $1,000.00 | $75,000 | $0.03 | 2,976,190 | 2,978.5 | I |
| 2011-08-12 | Purchase : show line 3 in the form Series E Convertible Preferred Stock | +125 | $1,000.00 | $125,000 | $0.02 | 5,040,323 | 3,112.5 | I |
Loading xslF345X03/primary_doc.xml…